These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 21050305)
21. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up. Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043 [TBL] [Abstract][Full Text] [Related]
22. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Cox C; White L; Allred N; Meyers M; Dickson D; Dupont E; Cantor A; Ly Q; Dessureault S; King J; Nicosia S; Vrcel V; Diaz N Ann Surg Oncol; 2006 May; 13(5):708-11. PubMed ID: 16538416 [TBL] [Abstract][Full Text] [Related]
23. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study. Bulte CS; van der Heiden-van der Loo M; Hennipman A Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809 [TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective. Catzeddu T; Bertelli G; Del Mastro L; Venturini M J Surg Oncol; 2004 Mar; 85(3):129-32. PubMed ID: 14991884 [TBL] [Abstract][Full Text] [Related]
25. [Sentinel lymph node biopsy with micrometastases in breast cancer: histological data and surgical implications. About a series of 201 axillary dissections after peroperative sentinel node identification]. Marin C; Mathelin C; Neuville A; Mertz L; Constantinesco A; Chenard MP; Bellocq JP Bull Cancer; 2003 May; 90(5):459-65. PubMed ID: 12850769 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. Noguchi M Br J Surg; 2002 Dec; 89(12):1505-15. PubMed ID: 12445058 [TBL] [Abstract][Full Text] [Related]
27. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit. Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346 [TBL] [Abstract][Full Text] [Related]
28. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)]. Degnim AC; Zakaria S; Boughey JC; Sookhan N; Reynolds C; Donohue JH; Farley DR; Grant CS; Hoskin T Ann Surg Oncol; 2010 Oct; 17(10):2685-9. PubMed ID: 20390457 [TBL] [Abstract][Full Text] [Related]
29. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer. Konstantiniuk P; Schrenk P; Reitsamer R; Koeberle-Wuehrer R; Tausch C; Roka S; Riedl O; Poestlberger S; Hecke D; Janauer M; Haid A Breast; 2007 Oct; 16(5):520-6. PubMed ID: 17566737 [TBL] [Abstract][Full Text] [Related]
30. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years. Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841 [TBL] [Abstract][Full Text] [Related]
31. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968 [TBL] [Abstract][Full Text] [Related]
32. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071 [TBL] [Abstract][Full Text] [Related]
33. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202 [TBL] [Abstract][Full Text] [Related]
34. Recent advances in sentinel lymph node biopsy for breast cancer. Goyal A; Mansel RE Curr Opin Oncol; 2008 Nov; 20(6):621-6. PubMed ID: 18841040 [TBL] [Abstract][Full Text] [Related]
35. Clinical impact of false-negative sentinel lymph nodes in breast cancer. Zavagno G; Del Bianco P; Koussis H; Artioli G; Carraro P; De Salvo GL; Mencarelli R; Belardinelli V; Marconato G; Nitti D Eur J Surg Oncol; 2008 Jun; 34(6):620-5. PubMed ID: 17764888 [TBL] [Abstract][Full Text] [Related]
36. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Saidi RF; Dudrick PS; Remine SG; Mittal VK Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910 [TBL] [Abstract][Full Text] [Related]
37. Lymphatic tumor burden negatively impacts the ability to detect the sentinel lymph node in breast cancer. Vargas HI; Vargas MP; Venegas R; Gonzalez KD; Burla M; Mishkin F; Khalkhali I Am Surg; 2003 Oct; 69(10):886-90. PubMed ID: 14570368 [TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node micrometastasis in human breast cancer: an update. Salhab M; Patani N; Mokbel K Surg Oncol; 2011 Dec; 20(4):e195-206. PubMed ID: 21788132 [TBL] [Abstract][Full Text] [Related]
39. Axillary sentinel lymph node micrometastases with extracapsular extension: a distinct pattern of breast cancer metastasis? Cserni G J Clin Pathol; 2008 Jan; 61(1):115-8. PubMed ID: 17468292 [TBL] [Abstract][Full Text] [Related]
40. Axillary management after sentinel lymph node biopsy in breast cancer patients. Rivers A; Hansen N Surg Clin North Am; 2007 Apr; 87(2):365-77, ix. PubMed ID: 17498532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]